Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial

NCT07835555 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07835555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07835555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial
Lead sponsor
Yale University
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2027
Completion date
September 30, 2031
Enrollment
794 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, tobacco use disorder/cigarette smoking